The second-worst Dow stock so far this year is The Procter & Gamble Co. (NYSE: PG), down 15.8%; followed by Walmart Inc. (NYSE: WMT), down 15.2%; 3M …
NEW YORK (Reuters) - Johnson & Johnson (:JNJ - News) shareholders have endured a painful year amid worries about prospects for its many businesses, but investors capitalizing on the stock's relatively cheap valuation may be set to …
Additionally, the firm is working with Johnson & Johnson to develop Zejula to treat prostate cancer. Another company in the mix with Roche is Clovis Oncology, …
Johnson & Johnson (NYSE: JNJ), meanwhile ... 10 stocks we like better than Verizon Communications When investing geniuses David and Tom Gardner have …
However, the stock is coming under pressure after issuing weaker than ... but …
CNBC10d
NEW YORK (AP) — Global stock indexes are declining Monday as investors remain ... LOSERS: Among health care companies, Johnson & Johnson lost 1.6 percent …
Interxion stock rose 1.7% to 65.07 in the stock market today, reclaiming its 50 …
It was expected to sell 4.7 million shares for between $14 and $16. The stock (NASDAQ:KZR) opened at $20 a share and rose as high as $20.48 before …
the addition of Walgreens stock means that the so-called divisor of the Dow will …
Another notable valuation metric for NANO is its P/B ratio of 3.54. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined …